A Short-Acting GLP-1 Analog or Prandial Insulin to Supplement Basal Insulin?—Moving Toward Personalized Management of Type 2 Diabetes Mellitus

Irl B. Hirsch; Doron Schneider; Aaron King; William H. Polonsky; Timothy S. Reid; Jay Shubrook; Carol A. Verderese; Jeffrey Wallace; Matthew C. Riddle

doi:10.3810/pgm.2014.05.2763

A Short-Acting GLP-1 Analog or Prandial Insulin to Supplement Basal Insulin?—Moving Toward Personalized Management of Type 2 Diabetes Mellitus

Postgraduate Medicine ◽

10.3810/pgm.2014.05.2763 ◽

2014 ◽

Vol 126 (3) ◽

pp. 135-144 ◽

Cited By ~ 2

Author(s):

Irl B. Hirsch ◽

Doron Schneider ◽

Aaron King ◽

William H. Polonsky ◽

Timothy S. Reid ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Short Acting ◽

Personalized Management ◽

Prandial Insulin

Download Full-text

Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification—a randomized phase IV trial: Indian subpopulation analyses

International Journal of Diabetes in Developing Countries ◽

10.1007/s13410-015-0387-z ◽

2015 ◽

Vol 37 (2) ◽

pp. 116-123

Author(s):

K. M. Prasanna Kumar ◽

Sanjiv Shah ◽

Parag Shah ◽

Simon Cleall ◽

Steve Chen ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Insulin Lispro ◽

Basal Insulin ◽

Once Daily ◽

Insulin Intensification ◽

Prandial Insulin

Download Full-text

Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus: Results over 52 weeks

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2017.05.010 ◽

2017 ◽

Vol 31 (8) ◽

pp. 1283-1285 ◽

Cited By ~ 6

Author(s):

Lawrence A. Leiter ◽

Jorge Luiz Gross ◽

Francis Chow ◽

Diane Miller ◽

Susan Johnson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Receptor Agonist ◽

Prandial Insulin ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Abstract #292 Efficacy of Hydroxychloroquine when added in Subjects with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Basal Insulin and Two Other Oral Antidiabetic Drugs

Endocrine Practice ◽

10.1016/s1530-891x(20)46636-4 ◽

2019 ◽

Vol 25 ◽

pp. 119-120

Author(s):

Arjun Baidya ◽

Ajay Chhabra

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive systematic review of current options

Diabetes & Metabolism ◽

10.1016/j.diabet.2016.11.007 ◽

2017 ◽

Vol 43 (2) ◽

pp. 110-124 ◽

Cited By ~ 8

Author(s):

D. Raccah

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Insulin Treatment ◽

Treatment Intensification

Download Full-text

How do short-acting insulin analogues compare with regular human insulin for adults with type 2 diabetes mellitus?

Cochrane Clinical Answers ◽

10.1002/cca.2514 ◽

2019 ◽

Author(s):

Adarsh Gupta

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Human Insulin ◽

Insulin Analogues ◽

Regular Human Insulin ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin

Download Full-text

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin

Drugs in Context ◽

10.7573/dic.212288 ◽

2015 ◽

pp. 1-7 ◽

Cited By ~ 1

Author(s):

Andrew Ahmann

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Basal Insulin

Download Full-text

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study

Patient Preference and Adherence ◽

10.2147/ppa.s194598 ◽

2019 ◽

Vol Volume 13 ◽

pp. 761-773 ◽

Cited By ~ 1

Author(s):

Kenneth J Tomaszewski ◽

Amy Allen ◽

Michelle Mocarski ◽

Alisa Schiffman ◽

Davida Kruger ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Health Care ◽

Type 2 Diabetes Mellitus ◽

Health Care Professionals ◽

Basal Insulin ◽

Diabetes Control ◽

The Us

Download Full-text

Efficacy and safety of the second generation basal insulin analogs in type 2 diabetes mellitus: A critical appraisal

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2019.04.014 ◽

2019 ◽

Vol 13 (3) ◽

pp. 1975-1989

Author(s):

Hernando Vargas-Uricoechea ◽

Juan Pablo Frias

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Second Generation ◽

Critical Appraisal ◽

Efficacy And Safety ◽

Insulin Analogs

Download Full-text

PDB61 COMPARE LIXISENATIDE WITH RAPID-ACTING INSULIN INTENSIFICATION REGIMENS ON TOP OF BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A COST PER RESPONDER AND NUMBER NEEDED TO TREAT ANALYSIS IN CHINA

Value in Health ◽

10.1016/j.jval.2019.04.610 ◽

2019 ◽

Vol 22 ◽

pp. S150-S151

Author(s):

P. Men ◽

S. Qu ◽

C. Li ◽

S. Zhai

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Number Needed To Treat ◽

Insulin Intensification ◽

Acting Insulin ◽

Cost Per Responder ◽

Treat Analysis

Download Full-text

Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi

Diabetes Therapy ◽

10.1007/s13300-019-0569-7 ◽

2019 ◽

Vol 10 (2) ◽

pp. 493-508 ◽

Cited By ~ 4

Author(s):

Johannes Pöhlmann ◽

Monika Russel-Szymczyk ◽

Pavel Holík ◽

Karel Rychna ◽

Barnaby Hunt

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Czech Republic ◽

Cost Effectiveness ◽

Basal Insulin ◽

The Czech Republic

Download Full-text